CLINICAL AND EXPERIMENTAL HYPERTENSION

Scope & Guideline

Empowering researchers to transform hypertension care.

Introduction

Immerse yourself in the scholarly insights of CLINICAL AND EXPERIMENTAL HYPERTENSION with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1064-1963
PublisherTAYLOR & FRANCIS INC
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 1978 to 2024
AbbreviationCLIN EXP HYPERTENS / Clin. Exp. Hypertens.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'Clinical and Experimental Hypertension' focuses on advancing the understanding of hypertension through innovative research and clinical studies. It encompasses a wide range of topics related to hypertension, including its pathophysiology, risk factors, treatment strategies, and the impact of comorbid conditions. The journal aims to disseminate high-quality research findings that can influence clinical practices and public health policies.
  1. Pathophysiology of Hypertension:
    Research exploring the underlying biological mechanisms that contribute to the development and progression of hypertension, including genetic, molecular, and cellular factors.
  2. Clinical Management and Treatment Strategies:
    Studies evaluating the efficacy of various antihypertensive therapies, including pharmacological and non-pharmacological interventions, and their impact on patient outcomes.
  3. Risk Factors and Epidemiology:
    Investigations into the risk factors associated with hypertension, including lifestyle, environmental, and genetic determinants, as well as epidemiological trends in different populations.
  4. Comorbid Conditions and Hypertension:
    Research focusing on the interactions between hypertension and other health conditions, such as diabetes, cardiovascular diseases, and kidney disorders.
  5. Innovative Diagnostic and Monitoring Techniques:
    Development and validation of new diagnostic tools and technologies for the assessment and monitoring of hypertension and related cardiovascular risks.
The journal has evolved to reflect the changing landscape of hypertension research. Recent publications indicate a shift towards emerging themes that are gaining traction among researchers and clinicians alike. This section outlines these trending topics that are increasingly shaping the discourse in hypertension.
  1. Role of Gut Microbiota in Hypertension:
    Recent studies have begun to explore the influence of gut microbiota on blood pressure regulation, indicating a novel area of research that connects metabolic health and hypertension.
  2. Impact of Inflammation and Immune Response:
    There is growing interest in the role of inflammatory processes and immune responses in the pathogenesis of hypertension, highlighting the importance of systemic inflammation as a potential therapeutic target.
  3. Use of Biomarkers for Hypertension Prediction:
    The identification and validation of novel biomarkers to predict hypertension risk and monitor treatment efficacy is increasingly prominent, reflecting a trend towards personalized medicine.
  4. Technological Innovations in Blood Pressure Monitoring:
    The emergence of wearable technology and advanced monitoring devices has led to a focus on real-time blood pressure assessment and management, indicating a shift towards more patient-centered care.
  5. Psychosocial Factors and Hypertension:
    Research examining the relationship between stress, mental health, and hypertension is on the rise, illustrating the importance of psychosocial factors in the management of blood pressure.

Declining or Waning

While 'Clinical and Experimental Hypertension' continues to be a leading journal in hypertension research, certain themes have shown a decline in prominence over recent years. This section highlights those areas that appear to be receiving less attention in current publications.
  1. Traditional Lifestyle Interventions:
    Research focusing on conventional lifestyle modifications, such as dietary changes and exercise, has seen a decline as newer, more innovative approaches and pharmacological treatments gain favor.
  2. Animal Models in Hypertension Research:
    There has been a noticeable decrease in studies utilizing animal models for hypertension research, as the focus shifts towards clinical trials and human studies that directly inform patient care.
  3. Static Epidemiological Studies:
    The prevalence of purely observational epidemiological studies without a strong experimental or intervention component has diminished, as the journal emphasizes studies that provide actionable insights into treatment and management.

Similar Journals

Diabetes & Metabolism Journal

Exploring innovative solutions in endocrinology.
Publisher: KOREAN DIABETES ASSOCISSN: 2233-6079Frequency: 6 issues/year

Diabetes & Metabolism Journal, published by the Korean Diabetes Association, is a leading open-access journal dedicated to advancing the field of endocrinology, with a specific focus on diabetes and metabolism. Since its establishment in 1991, the journal has provided a robust platform for disseminating high-quality research, contributing significantly to our understanding of diabetes pathophysiology, treatment, and prevention strategies. The journal boasts an impressive impact factor, ranking in the top quartile (Q1) of its category and occupying the 28th position out of 244 in Scopus rankings, which places it in the 88th percentile among its peers. With its commitment to open access, researchers, professionals, and students globally can explore the latest findings and innovative solutions in diabetes research. The journal continues to serve as an essential resource for those dedicated to improving patient outcomes and advancing scientific knowledge in the metabolic disorders domain.

DIABETES OBESITY & METABOLISM

Advancing knowledge in diabetes and obesity research.
Publisher: WILEYISSN: 1462-8902Frequency: 12 issues/year

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

Clinica e Investigacion en Arteriosclerosis

Elevating the standards of cardiovascular medicine through rigorous investigation.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Canadian Respiratory Journal

Empowering practitioners with vital insights in pulmonary health.
Publisher: HINDAWI LTDISSN: 1198-2241Frequency: 1 issue/year

The Canadian Respiratory Journal is a prominent peer-reviewed publication dedicated to advancing knowledge in the field of pulmonary and respiratory medicine. Published by HINDAWI LTD and based in Egypt, this journal has been an Open Access platform since 1994, ensuring broad dissemination of vital research findings to a global audience. With an ISSN of 1198-2241 and an E-ISSN of 1916-7245, the journal plays a significant role in shaping respiratory health discussions, evidenced by its 2023 category rankings of Q2 in Medicine (miscellaneous) and Q3 in Pulmonary and Respiratory Medicine. The journal consistently publishes high-quality research, reviews, and clinical guidelines that resonate with practitioners, researchers, and students alike. It serves as an essential resource for those seeking to stay at the forefront of developments in respiratory health, reflecting its commitment to enhancing practice and informing policy while recognizing its place in this vital medical field.

JOURNAL OF NEPHROLOGY

Championing advancements in nephrology since 1989.
Publisher: SPRINGER HEIDELBERGISSN: 1121-8428Frequency: 9 issues/year

JOURNAL OF NEPHROLOGY is a premier academic journal dedicated to the field of nephrology, published by Springer Heidelberg. With its ISSN 1121-8428 and E-ISSN 1724-6059, this journal serves as a dynamic platform for disseminating high-quality research and groundbreaking findings in kidney health and disease. Since its inception in 1989, it has established itself as a vital resource for professionals, researchers, and students, consistently ranking in the top quartile (Q1) of nephrology journals and securing an impressive Scopus rank of #19 out of 81, placing it in the 77th percentile. Although it operates under a subscription model, the journal fosters an inclusive academic environment where critical discussions and innovative approaches to nephrological challenges are encouraged. With a commitment to advancing knowledge and practice in nephrology, JOURNAL OF NEPHROLOGY remains an essential resource for anyone who seeks to stay at the forefront of kidney research and clinical care.

HYPERTENSION

Transforming research into practice for hypertension care.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0194-911XFrequency: 12 issues/year

HYPERTENSION, published by Lippincott Williams & Wilkins, is a preeminent journal in the field of cardiovascular medicine, focusing on the latest research, therapies, and clinical practices related to hypertension and its associated disorders. With a distinguished Q1 ranking in Internal Medicine and a commendable Scopus rank of #12 out of 167 in its category, it occupies a vital position within the academic community, appealing to researchers, clinicians, and educators alike. The journal has been disseminating impactful findings since 1979 and continues to influence the discourse on hypertension through rigorous peer-reviewed articles, reviews, and studies designed to elevate understanding and treatment of this prevalent condition. HYPERTENSION remains an essential resource for professionals keen on advancing their knowledge in this critical area of medicine, fostering innovations that ultimately improve patient care.

THROMBOSIS RESEARCH

Pioneering Insights in Hematology Research
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0049-3848Frequency: 12 issues/year

THROMBOSIS RESEARCH is a leading peer-reviewed journal in the field of hematology, published by PERGAMON-ELSEVIER SCIENCE LTD. With an impressive impact factor and ranked within the top 10 of 137 in its category according to Scopus, this journal provides a critical platform for the dissemination of innovative research related to thrombosis and hemostasis. Established in 1972, THROMBOSIS RESEARCH has been at the forefront of scholarly communication, addressing key issues, findings, and advancements over more than five decades. Recognized for its high-quality content, the journal is categorized in the Q1 quartile for 2023, reflecting its influence and relevance within the scientific community. Researchers, medical professionals, and students engaged in the study of blood disorders will find valuable insights and the latest discoveries within its pages. Although currently not an open-access publication, THROMBOSIS RESEARCH remains accessible to a wide audience through institutional subscriptions, ensuring that vital research continues to inform and enhance clinical practices around the globe.

AMERICAN JOURNAL OF HYPERTENSION

Transforming hypertension knowledge into practice.
Publisher: OXFORD UNIV PRESSISSN: 0895-7061Frequency: 12 issues/year

American Journal of Hypertension, published by Oxford University Press, is a leading peer-reviewed journal dedicated to the field of hypertension and cardiovascular health. With an ISSN of 0895-7061 and an E-ISSN of 1941-7225, this prestigious journal has been providing researchers and clinicians with significant advancements in hypertension research since its inception in 1954, with a continued focus on innovative studies through 2024. Ranked Q2 in Internal Medicine and positioned within the top 22% of its category according to Scopus, it is a vital resource for those involved in clinical practice and research aimed at understanding and managing hypertension. The journal disseminates pivotal findings, treatment updates, and guideline recommendations that contribute to improved patient care globally. Accessible solely through subscription, the American Journal of Hypertension is essential reading for professionals committed to enhancing cardiovascular health outcomes.

EUROPEAN JOURNAL OF HEART FAILURE

Empowering clinicians with cutting-edge heart failure knowledge.
Publisher: WILEYISSN: 1388-9842Frequency: 12 issues/year

The European Journal of Heart Failure, published by Wiley, is a premier international journal dedicated to advancing the field of cardiology, specifically focusing on heart failure research and clinical practices. With an impressive impact factor and ranked in the top 1% of journals in Cardiology and Cardiovascular Medicine according to Scopus rankings (Rank #7/387, Percentile 98th), this journal serves as a vital resource for researchers, clinicians, and students alike. Spanning from 1999 to 2024, the journal has established itself as a cornerstone for innovative research, comprehensive reviews, and clinical insights, fostering a deeper understanding of heart failure mechanisms, management, and treatment strategies. Although not an open-access journal, the European Journal of Heart Failure remains committed to disseminating high-quality, peer-reviewed content that contributes significantly to the global cardiovascular community. Located in the United States at 111 River St, Hoboken, NJ 07030-5774, it continues to play an essential role in shaping the future of heart failure management.

Translational Psychiatry

Championing open access to groundbreaking psychiatric research.
Publisher: SPRINGERNATUREISSN: 2158-3188Frequency: 1 issue/year

Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.